Daily Roundup Max

Every announcement for the day, ranked by impact score. · Standard version

Code Time Impact Headline
AD8 86 Response to ASX Aware Letter
RTH 77 Strategic Acquisition in Hong Kong
AHL 72 Revenue Growth Continues and Half Year Results Presentation
INA 71 Strong First Half Reflected in Recent FY25 Guidance Upgrade
KME 70 Half Yearly Report and Accounts
CSX 68 H1 FY25 Results
CSX 68 Appendix 4D and Interim Report
FEX 67 Fenix to Acquire CZR
WGX 67 BC8: Lakewood Acquisition Drives Gold Acceleration Strategy
SDF 66 1H25 results investor presentation
SDF 66 1H25 results market release
SDF 66 Appendix 4D and half year report 2025
SGI 66 Stealth 1H FY25 Briefing Presentation
SGI 66 Stealth delivers significant financial performance in 1H25
SGI 66 Stealth 1H FY25 4D and Interim Financial Report
DRO 66 Appendix 4E and Annual Report
PAT 66 Option to Acquire Exploration Licences in the Mumbwa Region
WDS 66 Annual Report 2024
CZR 66 Fenix to Acquire CZR
MAD 66 1H FY25 Financial Results & Interim Dividend
TTT 66 Acquisition of Huntsville, Alabama Manufacturing Facility
MAD 66 Appendix 4D
AVA 66 Investor Presentation
AVA 66 1H FY25 Results Announcement
AVA 66 Appendix 4D and 1H25 Financial Report
BC8 66 Lakewood Acquisition Drives Gold Acceleration Strategy
I88 66 Infini To Acquire Major Footprint In Athabasca Basin
IRE 65 Clarification of Underlying Profit Measures
XPN 64 XPON Half Year Results Investor Presentation FY25
XPN 64 XPON Half Year Results Release FY25
AHL 64 Appendix 4D and Half Year Accounts
BEZ 64 Market Update
CYC 64 Preliminary Final Report
AUB 64 1H25 Results - Investor Presentation
AUB 64 1H25 Results - Performance Overview
AUB 64 Appendix 4D and Half Year Financial Report
BRL 63 Half year results - December 2024
HLI 63 2024 Full Year Results Investor Presentation
HLI 63 2024 Full Year Results
VEA 63 Appendix 4E and 2024 Annual Report
GEM 63 FY24 Full Year Results Media Release
AGI 62 App4E Preliminary Final Report for Year Ended 31.12.24
ESK 62 Preliminary Final Report
JLG 62 1H25 Results Announcement
JLG 62 1H25 Results Presentation
JLG 62 1H25 Appendix 4D and Interim Financial Report
MCY 62 2025 Half Year Results Presentation
KYP 61 Half Yearly Report and Accounts
EZL 61 Half Yearly Report and Accounts
HMD 61 Strategic Collaboration Agreement with Garmin Health
TLX 61 Telix Announces Change in Reporting Currency to USD
PPS 61 Investor Presentation - H1 FY2025 Results
PPS 61 2025 Half-Year Results
PPS 61 Half Yearly Report and Accounts
3DP 61 Half Yearly Report and Accounts
FSF 60 Suspension from Quotation
RHK 60 Suspension from Quotation
SVR 60 Solvar H1 FY25 Investor Presentation
SVR 60 Solvar H1 FY25 Results
SVR 60 Appendix 4D and Interim Financial Report
MAT 60 Suspension from Quotation
EVS 60 NBIO received from Ideagen
SGQ 60 Suspension from Quotation
ZIP 60 1H FY25 Results Update
ZIP 60 1H FY25 Investor Presentation
AXP 60 Managing Director Appointment and CEO Resignation
ZIP 60 Half Yearly Report and Accounts
WDS 60 Woodside Releases Full-Year 2024 Results
DMP 60 Half Year 2025 Media Release
DMP 60 Half Year 2025 Market Presentation
DMP 60 Appendix 4D & Financial Statements FY2025
SPA 58 Investor Presentation
SPA 58 1H25 Results Announcement
SPA 58 Appendix 4D and 1H25 Financial Report
EPY 58 Dividend/Distribution - EPY
MYG 58 Half Yearly Report and Accounts
RAC 58 Appendix 4D & Half-Year Financial Statements
XPN 58 XPON Interim Financial Statements and Appendix 4D
CUE 58 1H FY2025 Results and Interim Dividend
CUE 58 Appendix 4D and Half Year Report
CIP 58 CIP HY25 Property Compendium
CIP 58 CIP HY25 Results Presentation
EPY 58 Half Year Accounts
CIP 58 CIP HY25 Results Announcement
CIP 58 CIP HY25 Appendix 4D
IDT 58 1HFY25 Results Presentation
NEC 58 Interim results presentation
NEC 58 Interim Results Announcement
NEC 58 Half Year Accounts
CYC 58 CYC Results Summary
SSH 57 SSH Group Ltd - Appendix 4D
FSA 57 Appendix 4D and Half Yearly Report
FSA 57 Dividend/Distribution - FSA
NWH 57 NRW Holdings Whyalla SIMEC Update
NOX 57 Appendix 4D and FY2025 Half Year Financial Report
BRL 57 Half Year Financial Statements - December 2024
KCN 57 Appendix 4D & Half Year Report
ST1 57 H1 FY25 Results Presentation
OBL 57 Financial Close of Fund 9
ST1 57 Appendix 4D - Half Year Accounts
BRK 57 Brookside Energy Spuds Ninth Well in SWISH Play
AMO 57 Appendix 4D and Half Year Financial Report
AYA 57 Appendix 4D and Interim Financial Report
AXQ 57 Appendix 4D and Half Year Financial Report
INA 57 Appendix 4D and Interim Financial Reports
DXB 57 Half-Year Financial Report & Appendix 4D - 31 December 2024
AXE 57 Improved Biochip Accuracy Paves Way for Human Blood Testing
4DX 57 Share Purchase Plan Offer Booklet
FEX 57 CZR: Target's Statement
TEE 57 Aggressive Leasing Strategy In Kansas
VEA 57 Results presentation - financial year ended 31 Dec 2024
VEA 57 Viva Energy Results - financial year ended 31 Dec 2024
4DX 57 4DMedical gains regulatory approval for CT LVAS in Canada
HLI 57 Appendix 4E
FEX 57 Fenix Bidder's Statement
EOS 57 2024 Results Investor Presentation
QAL 57 1H25 Results Presentation
FEX 57 Appendix 4D
EOS 57 Appendix 4E and 2024 Financial Report
QAL 57 1H25 Results Announcement
GEM 57 FY24 Investor Presentation
LRK 57 HY25 Investor Briefing
LRK 57 HY25 Results
LRK 57 HY25 Appendix 4D & Half Year Report
GEM 57 FY24 Financial and Statutory Report & Appendix 4E
CBL 57 Private Placement
SSH 57 SSH Advances Mining Services Division with Key Developments
AEL 57 H1 FY25 Results Summary
AEL 57 1H FY25 Results Presentation
AEL 57 Otway Basin JV Update
QAL 57 Appendix 4D and 1H25 Interim Financial Report
AEL 57 H1 FY25 Financial Report
THL 57 FY25 Interim Results - NZX Distribution Notice
THL 57 FY25 Interim Results - NZX Results Announcement Form
THL 57 FY25 Interim Results - Investor Presentation
THL 57 FY25 Interim Results - Market Release
THL 57 FY25 Interim Financial Statements, Chair & CEO Letter
ERG 56 Half Yearly Report and Accounts
VN8 56 Financial Results Announcement & Appointment of new CEO
TEK 56 Appendix 4D and 2025 Half-Year Financial Statements
ICG 56 Bidder's Statement for Stunalara Metals Limited
WGN 56 H1 FY25 Results Announcement
WGN 56 H1 FY25 Results Investor Presentation
AGI 56 CY24 Full Year Financial Results Investor Presentation
AGI 56 CY24 Full Year Financial Results 31.12.24
WGN 56 Wagners Appendix 4D and Half Year Report
PAX 56 Investment team changes
PIX 56 Investment team changes
PMC 56 Investment team changes at investment manager
PAI 56 Investment team changes at investment manager
EDC 56 Notification of buy-back - EDC
CIN 56 Chairman's Report to Shareholders
OSL 56 Appendix 4D and Half Year Accounts
RF1 56 Appendix 4D and Half Year Report 31 December 2024
ACR 56 Investor Presentation February 2025
ACR 56 Appendix 4D and December 2024 Half Year Accounts
PTM 56 2024/2025 Half Year Financial Results Analyst Briefing
PTM 56 PTM - Investment leadership changes and turnaround progress
PTM 56 Appendix 4D and Half-Year Financial Report
CIN 56 Half Yearly Report and Accounts
SFY 56 Half Yearly Report and Accounts
SLF 56 Half Yearly Report and Accounts
STW 56 Half Yearly Report and Accounts
OM1 56 Company Update
KSC 56 KSC Announces results for Half Year Ended 31 December 2024
FPP 56 Appendix 4D & December 2024 Half Year financials
RCT 56 Trading Halt
RCT 56 Pause in Trading
TGH 56 TGH Appendix 4D and Half Year Financial Statements
RR1 56 Response to ASX Aware Query
KSC 56 Appendix 4D
AYI 56 Half Year Accounts to 31 December 2023
AAM 56 Commencement of its Winter Drill Program at Bunker Hill
E79 56 Response to ASX Aware Letter
EDC 56 HY25 Results Presentation
EDC 56 HY25 Results Announcement
EDC 56 HY25 Appendix 4D and Interim Financial Report
GNM 56 Response to ASX Price and Volume Query
TSI 56 Update on ATO Debt Recovery Proceedings
KBC 56 TOV: BHD Panel Receives Applications
BHD 56 TOV: BHD Panel Receives Applications
NH3 56 Investor Webinar Presentation
ANR 56 Appendix 4D & Half Year Report 31 December 2024
APC 56 Trading Halt
APC 56 Pause in trading
MEU 56 Investor Update February 2025
CMB 56 FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol
EGH 56 1H25 Investor presentation
EGH 56 1H25 Results Announcement
BTH 56 Half Year FY24 Results Announcement
EGH 56 Appendix 4D and Half Year Financial Report
BTH 56 Half Year Financial Report and Appendix 4D
MX1 56 MX1 - Extension of Retail Entitlement Offer
IBC 56 Half Yearly Report and Accounts
AJX 56 Half Year Report and Accounts
RWL 56 1H FY25 Results Presentation
WOA 56 Chinese Market Approval for WOA's Lupin Protein Isolate
RMC 56 Investor Presentation
RMC 56 Resimac announces 1H25 results
LDR 56 UP TO 31.9% ANTIMONY AND 5,460 g/t SILVER